Literature DB >> 2948905

Effect of cyclosporin A on the T-effector and T-suppressor cell response in contact sensitivity.

M Braida, J Knop.   

Abstract

The effect of cyclosporin A (CyA) on the induction, expression and regulation of the immune response to the contact sensitivity agent 2,4-dinitroflouro-benzene, (DNFB) has been studied in BALB/c mice. CyA was administered orally during the sensitization phase or during the elicitation phase. The following results were obtained. CyA administered orally during the sensitization phase at a high dose resulted in a reduction of the contact sensitivity response. Feeding lower doses had no effect on the ear swelling response. CyA inhibited the ear swelling response if administered during the elicitation phase. In transfer experiments it was shown that the induction of the T-effector cell of delayed hypersensitivity (TDH) was insensitive to the suppressive action of CyA, while the effector function of this T-cell subpopulation was CyA-sensitive. T-suppressor (TS) cell response was studied in animals by inducing tolerance through epicutaneous application of an allergen overload and by transfer of TS cells induced by intravenous injection of the contact sensitizer. Tolerance induction in vivo and TS-cell induction and function were inhibited in CyA-treated animals.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2948905      PMCID: PMC1453321     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  27 in total

1.  The effects of cyclosporin A on the induction, expression and regulation of the immune response to herpes simplex virus.

Authors:  D M Altmann; W A Blyth
Journal:  Clin Exp Immunol       Date:  1985-01       Impact factor: 4.330

Review 2.  Cyclosporine--an overview of recent advances.

Authors:  M I Lorber; B D Kahan
Journal:  Year Immunol       Date:  1985

Review 3.  Suppressive mechanisms involving sensitization and tolerance in contact allergy.

Authors:  H N Claman; S D Miller; M S Sy; J W Moorhead
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

4.  Cyclosporin A inhibits the proliferative response and the generation of helper, suppressor and cytotoxic T-cell functions in the autologous mixed lymphocyte reaction.

Authors:  R Palacios
Journal:  Cell Immunol       Date:  1981-07-01       Impact factor: 4.868

5.  Effect of cyclosporin A on human lymphocyte responses in vitro. II. Induction of specific alloantigen unresponsiveness mediated by a nylon wool adherent suppressor cell.

Authors:  A D Hess; P J Tutschka; G W Santos
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

6.  Reversal of acute rejection episodes by cyclosporin A in dogs receiving renal allografts.

Authors:  W P Homan; J W Fabre; M E French; P R Millard; T G Denton; P J Morris
Journal:  Transplantation       Date:  1980-03       Impact factor: 4.939

7.  Rejection of long-surviving mouse skin allografts after withdrawal of cyclosporin A therapy.

Authors:  S P Lems; P J Capel; R A Koene
Journal:  Transplant Proc       Date:  1980-06       Impact factor: 1.066

8.  Inhibition of contact sensitivity reactions to DNFB by topical cyclosporin application in the guinea-pig.

Authors:  R D Aldridge; A W Thomson; R Rankin; P H Whiting; C Cunningham; J G Simpson
Journal:  Clin Exp Immunol       Date:  1985-01       Impact factor: 4.330

9.  Modulation of suppressor mechanisms in allergic contact dermatitis: 1. Effect of C. parvum on the induction phase of contact allergy.

Authors:  J Knop; R Riechmann; E Macher
Journal:  J Invest Dermatol       Date:  1981-03       Impact factor: 8.551

10.  Modulation of suppressor mechanisms in allergic contact dermatitis: 2. Inhibition of suppressor T-lymphocytes by Corynebacterium parvum.

Authors:  J Knop; R Riechmann; E Macher
Journal:  J Invest Dermatol       Date:  1981-05       Impact factor: 8.551

View more
  8 in total

1.  Effects of cyclosporin A on the cells responsible for the anticryptococcal cell-mediated immune response and its regulation.

Authors:  P L Fidel; J W Murphy
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

2.  Effects of topical cyclosporin A on guinea-pig toxic contact dermatitis.

Authors:  M Yokoo; D Oka; S Nakagawa
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

Review 3.  Management of high-risk corneal transplantation.

Authors:  Antonio Di Zazzo; Ahmad Kheirkhah; Tulio B Abud; Sunali Goyal; Reza Dana
Journal:  Surv Ophthalmol       Date:  2016-12-22       Impact factor: 6.048

4.  The efficacy of topical 0.05 % cyclosporine A in patients with dry eye disease associated with Sjögren's syndrome.

Authors:  Hülya Devecı; Senol Kobak
Journal:  Int Ophthalmol       Date:  2014-01-19       Impact factor: 2.031

Review 5.  The influence of cyclosporin A on cell-mediated immunity.

Authors:  A W Thomson; L M Webster
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

6.  Augmentation of delayed-type hypersensitivity to high dose sheep erythrocytes by cyclosporin A in the mouse: influence of drug dosage and route of administration and analysis of spleen cell populations.

Authors:  L M Webster; A W Thomson
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

7.  Anti-schistosomal activity of cyclosporin A: studies on murine spleen cells and the influence of a cyclosporin antagonist on resistance to infection.

Authors:  L R Brannan; L H Chappell; J Woo; A W Thomson
Journal:  Immunology       Date:  1989-07       Impact factor: 7.397

Review 8.  Systemic Immunomodulatory Strategies in High-risk Corneal Transplantation.

Authors:  Tulio B Abud; Antonio Di Zazzo; Ahmad Kheirkhah; Reza Dana
Journal:  J Ophthalmic Vis Res       Date:  2017 Jan-Mar
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.